Concepedia

Alyson B. Barnes

AB

Statistics

Publications

5

Citations

257

H-Index

5

Active since

2016

Affiliations

Duke University(Current)

Friedrich-Loeffler-Institut

National Institutes of Health

University of Virginia

Alyson B. Barnes is an author at Duke University specializing in antiviral therapeutics, viral infections, and bacterial pathogenesis.

ORCID

Publications per year

2016–2022

5

Publications

5

The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection

Elizabeth A. Nelson, Julie Dyall, Thomas Hoenen et al. · PLoS neglected tropical diseases · 2017 · 120 citations · Full text

, , +17

The bacterial effector GarD shields Chlamydia trachomatis inclusions from RNF213-mediated ubiquitylation and destruction

Stephen C. Walsh, Jeffrey R. Reitano, Mary S Dickinson et al. · Cell Host & Microbe · 2022 · 66 citations · Full text

, , +11

Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications

Elizabeth A. Nelson, Alyson B. Barnes, Ronald D. Wiehle et al. · Viruses · 2016 · 44 citations · Full text

, , +14

Modeling of variables in cellular infection reveals CXCL10 levels are regulated by human genetic variation and the Chlamydia-encoded CPAF protease

Benjamin H. Schott, Alejandro L. Antonia, Liuyang Wang et al. · Scientific Reports · 2020 · 17 citations · Full text

, , +17

Variation in Leishmania chemokine suppression driven by diversification of the GP63 virulence factor

Alejandro L. Antonia, Alyson B. Barnes, Amelia T. Martin et al. · PLoS neglected tropical diseases · 2021 · 10 citations · Full text

, , +17

1–5 of 5